Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AtriCure, Inc.ATRC · Entity 2704 | Director | July 28, 2026 | July 30, 2026 |
| Proto Labs IncPRLB · Entity 4553 | Director | June 02, 2026 | June 04, 2026 |
| SPS COMMERCE INCSPSC · Entity 4230 | Director | May 13, 2025 | May 15, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AtriCure, Inc.
Report date July 28, 2026 · Filed July 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,518 |
Ending reported balance
After 2026-07-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-07-28 · Exercise / conversion · Acquired 25,000 · Balance 65,518 Row 2 · 2026-07-28 · Sale · Disposed 25,000 · Balance 40,518 F1: This transaction was executed in multiple trades at prices ranging from $37.73 to $39.04 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Non-qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.95 · Expires 2026-11-11 | Direct | 0 |
Reported balance
After 2026-07-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-07-28 · Exercise / conversion · Disposed 25,000 · Balance 0 F2: These options were granted on November 11, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $37.73 to $39.04 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: These options were granted on November 11, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.
Proto Labs Inc
Report date June 02, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 32,505 |
Ending reported balance
After 2026-06-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-02 · Sale · Disposed 1,500 · Balance 33,005 F1: Reflects the weighted average price of 1,500 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on June 2, 2026, with sale prices ranging from $76.86 to $77.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 2 · 2026-06-02 · Sale · Disposed 500 · Balance 32,505 |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the weighted average price of 1,500 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on June 2, 2026, with sale prices ranging from $76.86 to $77.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
SPS COMMERCE INC
Report date May 13, 2025 · Filed May 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,522 |
Reported balance
After 2025-05-13 transaction · row 1
1 source rowRow 1 · 2025-05-13 · Grant · Acquired 1,310 · Balance 17,522 F1: This reflects a restricted stock unit award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2025, provided the recipient remains a member of the board as of the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: This reflects a restricted stock unit award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2025, provided the recipient remains a member of the board as of the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2026 Filed Jul 30, 2026 20:57 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $19.95 | $0.00 |
DisclosureSEC source: 0001205069-26-000005 · wk-form4_1785445070.xml · derivative · entry 3 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Non-qualified Stock Option (right to buy) · 25,000 shares Expires 2026-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on November 11, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| July 28, 2026 Filed Jul 30, 2026 20:57 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 25,000 | $37.84 | $946,000.00 |
DisclosureSEC source: 0001205069-26-000005 · wk-form4_1785445070.xml · nonDerivative · entry 2 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,518 F1 · price: This transaction was executed in multiple trades at prices ranging from $37.73 to $39.04 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 28, 2026 Filed Jul 30, 2026 20:57 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 25,000 | $19.95 | $498,750.00 |
DisclosureSEC source: 0001205069-26-000005 · wk-form4_1785445070.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:53 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 500 | $78.38 | $39,190.00 |
DisclosureSEC source: 0001628280-26-040863 · wk-form4_1780606432.xml · nonDerivative · entry 2 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,505 Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:53 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 1,500 | $76.91 | $115,360.05 |
DisclosureSEC source: 0001628280-26-040863 · wk-form4_1780606432.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,005 F1 · price: Reflects the weighted average price of 1,500 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on June 2, 2026, with sale prices ranging from $76.86 to $77.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:05 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 2,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-037234 · wk-form4_1779393912.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,505 F1 · shares: Deferred stock units that vest in full on the earlier of the first anniversary of the grant date or the date of the 2027 Annual Meeting of Shareholders but must be retained until the reporting person's service on the Company's Board of Directors ends. Read SEC document |
| May 18, 2026 Filed May 20, 2026 13:25 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 6,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001205069-26-000003 · wk-form4_1779283518.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,518 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 21:43 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 4,967 | $0.00 Strike: $19.95 | $0.00 |
DisclosureSEC source: 0001205069-25-000007 · wk-form4_1764193388.xml · derivative · entry 6 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Non-qualified Stock Option (right to buy) · 4,967 shares Expires 2026-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on November 11, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 21:43 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 4,967 | $38.00 | $188,746.00 |
DisclosureSEC source: 0001205069-25-000007 · wk-form4_1764193388.xml · nonDerivative · entry 4 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,374 Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 21:43 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 4,967 | $19.95 | $99,091.65 |
DisclosureSEC source: 0001205069-25-000007 · wk-form4_1764193388.xml · nonDerivative · entry 3 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 21:43 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 5,033 | $0.00 Strike: $19.95 | $0.00 |
DisclosureSEC source: 0001205069-25-000007 · wk-form4_1764193388.xml · derivative · entry 5 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,967 Underlying: Non-qualified Stock Option (right to buy) · 5,033 shares Expires 2026-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on November 11, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 21:43 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 5,033 | $37.32 | $187,831.56 |
DisclosureSEC source: 0001205069-25-000007 · wk-form4_1764193388.xml · nonDerivative · entry 2 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,374 F1 · price: This transaction was executed in multiple trades at prices ranging from $37.32 to $38.00 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 21:43 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 5,033 | $19.95 | $100,408.35 |
DisclosureSEC source: 0001205069-25-000007 · wk-form4_1764193388.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 12:27 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $19.95 | $0.00 |
DisclosureSEC source: 0001205069-25-000005 · wk-form4_1756211221.xml · derivative · entry 3 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Non-qualified Stock Option (right to buy) · 5,000 shares Expires 2026-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on November 11, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 12:27 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 5,000 | $37.00 | $185,000.00 |
DisclosureSEC source: 0001205069-25-000005 · wk-form4_1756211221.xml · nonDerivative · entry 2 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,374 Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 12:27 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 5,000 | $19.95 | $99,750.00 |
DisclosureSEC source: 0001205069-25-000005 · wk-form4_1756211221.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 13:04 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $19.95 | $0.00 |
DisclosureSEC source: 0001205069-25-000003 · wk-form4_1755781460.xml · derivative · entry 3 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Non-qualified Stock Option (right to buy) · 5,000 shares Expires 2026-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on November 11, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 13:04 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 5,000 | $36.00 | $180,000.00 |
DisclosureSEC source: 0001205069-25-000003 · wk-form4_1755781460.xml · nonDerivative · entry 2 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,374 Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 13:04 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 5,000 | $19.95 | $99,750.00 |
DisclosureSEC source: 0001205069-25-000003 · wk-form4_1755781460.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2025 Filed May 28, 2025 21:51 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 3,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-028218 · wk-form4_1748469081.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,295 F1 · shares: Deferred stock units that vest in full on the first anniversary of the grant date or the date but must be retained by the reporting person until the completion of the reporting person's service on the Company's Board of Directors. Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:42 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 5,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-25-000060 · wk-form4_1747860116.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,374 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:14 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantCommon Stock | 1,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-026047 · wk-form4_1747343667.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,522 F1 · shares: This reflects a restricted stock unit award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2025, provided the recipient remains a member of the board as of the vesting date. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:44 UTC | SPS COMMERCE INC SPSC · Entity 4230 | Exercise / conversionStock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $93.40 | $0.00 |
DisclosureSEC source: 0001437749-24-026426 · rdgdoc.xml · derivative · entry 5 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 860 Underlying: Common Stock · 2,000 shares Expires 2028-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:44 UTC | SPS COMMERCE INC SPSC · Entity 4230 | SaleCommon Stock | 542 | $202.63 | $109,825.35 |
DisclosureSEC source: 0001437749-24-026426 · rdgdoc.xml · nonDerivative · entry 4 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,212 F3 · price: Reflects the weighted average price of 542 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on August 9, 2024, with sales prices ranging from $202.56 to $202.77 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:44 UTC | SPS COMMERCE INC SPSC · Entity 4230 | SaleCommon Stock | 400 | $202.14 | $80,855.00 |
DisclosureSEC source: 0001437749-24-026426 · rdgdoc.xml · nonDerivative · entry 3 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,754 F2 · price: Reflects the weighted average price of 400 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on August 9, 2024, with sales prices ranging from $201.54 to $202.42 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:44 UTC | SPS COMMERCE INC SPSC · Entity 4230 | SaleCommon Stock | 1,058 | $200.40 | $212,023.83 |
DisclosureSEC source: 0001437749-24-026426 · rdgdoc.xml · nonDerivative · entry 2 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,154 F1 · price: Reflects the weighted average price of 1,058 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on August 9, 2024, with sales prices ranging from $200.25 to $201.21 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:44 UTC | SPS COMMERCE INC SPSC · Entity 4230 | Exercise / conversionCommon Stock | 2,000 | $93.40 | $186,800.00 |
DisclosureSEC source: 0001437749-24-026426 · rdgdoc.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,212 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:22 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 4,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-018334 · rdgdoc.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,356 F1 · shares: Deferred stock units ("DSUs") that vest in full on the date of the 2025 Annual Meeting of Shareholders, provided that the date of the 2025 Annual Meeting of Shareholders is at least 50 weeks after the date of the grant. DSUs must be retained by the reporting person until the completion of the reporting person's service on the Company's Board of Directors. Read SEC document |
| May 16, 2024 Filed May 21, 2024 00:07 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantStock Option (right to buy) · Derivative | 1,136 | $0.00 Strike: $80.31 | $0.00 |
DisclosureSEC source: 0001437749-24-017739 · rdgdoc.xml · derivative · entry 2 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,136 Underlying: Common Stock · 1,136 shares Expires 2031-05-16 F2 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2024, provided the reporting person remains a member of the board as of the vesting date. Read SEC document |
| May 16, 2024 Filed May 21, 2024 00:07 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantCommon Stock | 465 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-017739 · rdgdoc.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,212 F1 · shares: The deferred stock units will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2024, provided the reporting person remains a member of the board as of the vesting date. The deferred stock units must be retained until completion of the reporting person's service on the board, and upon completion of such service, convert into an equal number of shares of our common stock. The reporting person may defer receipt of the shares for up to ten years after completion of service. Read SEC document |
| May 13, 2024 Filed May 14, 2024 21:04 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 7,788 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-24-000079 · wk-form4_1715720668.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,973 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:06 UTC | SPS COMMERCE INC SPSC · Entity 4230 | Exercise / conversionStock Option (right to buy) · Derivative | 768 | $0.00 Strike: $59.00 | $0.00 |
DisclosureSEC source: 0001437749-24-004613 · rdgdoc.xml · derivative · entry 10 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 768 shares Expires 2027-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:06 UTC | SPS COMMERCE INC SPSC · Entity 4230 | SaleCommon Stock | 1,640 | $198.41 | $325,397.81 |
DisclosureSEC source: 0001437749-24-004613 · rdgdoc.xml · nonDerivative · entry 8 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,747 Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:06 UTC | SPS COMMERCE INC SPSC · Entity 4230 | SaleCommon Stock | 768 | $194.08 | $149,054.36 |
DisclosureSEC source: 0001437749-24-004613 · rdgdoc.xml · nonDerivative · entry 7 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,387 Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:06 UTC | SPS COMMERCE INC SPSC · Entity 4230 | Exercise / conversionCommon Stock | 768 | $59.00 | $45,312.00 |
DisclosureSEC source: 0001437749-24-004613 · rdgdoc.xml · nonDerivative · entry 6 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 22:06 UTC | SPS COMMERCE INC SPSC · Entity 4230 | Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $59.00 | $0.00 |
DisclosureSEC source: 0001437749-24-004613 · rdgdoc.xml · derivative · entry 9 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 768 Underlying: Common Stock · 3,000 shares Expires 2027-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 22:06 UTC | SPS COMMERCE INC SPSC · Entity 4230 | SaleCommon Stock | 400 | $195.71 | $78,285.52 |
DisclosureSEC source: 0001437749-24-004613 · rdgdoc.xml · nonDerivative · entry 5 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,387 F4 · price: Reflects the weighted average price of 400 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on February 14, 2024, with sales prices ranging from $195.45 to $196.08 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 22:06 UTC | SPS COMMERCE INC SPSC · Entity 4230 | SaleCommon Stock | 842 | $194.88 | $164,087.70 |
DisclosureSEC source: 0001437749-24-004613 · rdgdoc.xml · nonDerivative · entry 4 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,787 F3 · price: Reflects the weighted average price of 842 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on February 14, 2024, with sales prices ranging from $194.32 to $195.23 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 22:06 UTC | SPS COMMERCE INC SPSC · Entity 4230 | SaleCommon Stock | 800 | $193.64 | $154,914.80 |
DisclosureSEC source: 0001437749-24-004613 · rdgdoc.xml · nonDerivative · entry 3 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,629 F2 · price: Reflects the weighted average price of 800 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on February 14, 2024, with sales prices ranging from $193.31 to $194.17 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 22:06 UTC | SPS COMMERCE INC SPSC · Entity 4230 | SaleCommon Stock | 958 | $192.22 | $184,145.61 |
DisclosureSEC source: 0001437749-24-004613 · rdgdoc.xml · nonDerivative · entry 2 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,429 F1 · price: Reflects the weighted average price of 958 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on February 14, 2024, with sales prices ranging from $192.03 to $192.65 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 22:06 UTC | SPS COMMERCE INC SPSC · Entity 4230 | Exercise / conversionCommon Stock | 3,000 | $59.00 | $177,000.00 |
DisclosureSEC source: 0001437749-24-004613 · rdgdoc.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2023 Filed Nov 3, 2023 21:14 UTC | SPS COMMERCE INC SPSC · Entity 4230 | Exercise / conversionStock Option (right to buy) · Derivative | 500 | $0.00 Strike: $59.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054384 · doc4.xml · derivative · entry 9 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,768 Underlying: Common Stock · 500 shares Expires 2027-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2020, provided the reporting person remains a member of the board as of the vesting date. Read SEC document |
| November 02, 2023 Filed Nov 3, 2023 21:14 UTC | SPS COMMERCE INC SPSC · Entity 4230 | SaleCommon Stock | 500 | $163.97 | $81,983.00 |
DisclosureSEC source: 0001209191-23-054384 · doc4.xml · nonDerivative · entry 6 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,387 F3 · price: Reflects the weighted average price of 500 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on November 2, 2023, with sales prices ranging from $163.51 to $164.225 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 02, 2023 Filed Nov 3, 2023 21:14 UTC | SPS COMMERCE INC SPSC · Entity 4230 | Exercise / conversionCommon Stock | 500 | $59.00 | $29,500.00 |
DisclosureSEC source: 0001209191-23-054384 · doc4.xml · nonDerivative · entry 5 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 21:14 UTC | SPS COMMERCE INC SPSC · Entity 4230 | Exercise / conversionStock Option (right to buy) · Derivative | 268 | $0.00 Strike: $59.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054384 · doc4.xml · derivative · entry 8 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,268 Underlying: Common Stock · 268 shares Expires 2027-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2020, provided the reporting person remains a member of the board as of the vesting date. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 21:14 UTC | SPS COMMERCE INC SPSC · Entity 4230 | Exercise / conversionStock Option (right to buy) · Derivative | 732 | $0.00 Strike: $51.80 | $0.00 |
DisclosureSEC source: 0001209191-23-054384 · doc4.xml · derivative · entry 7 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 732 shares Expires 2026-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 21:14 UTC | SPS COMMERCE INC SPSC · Entity 4230 | SaleCommon Stock | 120 | $161.13 | $19,336.15 |
DisclosureSEC source: 0001209191-23-054384 · doc4.xml · nonDerivative · entry 4 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,387 F2 · price: Reflects the weighted average price of 120 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on November 1, 2023, with sales prices ranging from $161.08 to $161.255 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 21:14 UTC | SPS COMMERCE INC SPSC · Entity 4230 | SaleCommon Stock | 880 | $160.36 | $141,117.33 |
DisclosureSEC source: 0001209191-23-054384 · doc4.xml · nonDerivative · entry 3 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,507 F1 · price: Reflects the weighted average price of 880 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on November 1, 2023, with sales prices ranging from $160.08 to $161.07 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 21:14 UTC | SPS COMMERCE INC SPSC · Entity 4230 | Exercise / conversionCommon Stock | 268 | $59.00 | $15,812.00 |
DisclosureSEC source: 0001209191-23-054384 · doc4.xml · nonDerivative · entry 2 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 21:14 UTC | SPS COMMERCE INC SPSC · Entity 4230 | Exercise / conversionCommon Stock | 732 | $51.80 | $37,917.60 |
DisclosureSEC source: 0001209191-23-054384 · doc4.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.